Join Growin Stock Community!

Valneva seVALN.US Overview

US StockHealthcare
(No presentation for VALN)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

VALN AI Insights

VALN Overall Performance

VALN AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

VALN Recent Performance

-1.76%

Valneva se

0.05%

Avg of Sector

-0.31%

S&P500

VALN PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

VALN Key Information

VALN Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

VALN Profile

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is headquartered in Saint-Herblain, France.

Price of VALN

VALN FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

VALN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.19
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
5.36
PB Ratio
5.40
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
45.36%
Net Margin
-56.78%
Revenue Growth (YoY)
13.48%
Profit Growth (YoY)
33.43%
3-Year Revenue Growth
-42.74%
3-Year Profit Growth
-64.73%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.19
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
5.36
PB Ratio
5.40
Price-to-FCF
-
Gross Margin
45.36%
Net Margin
-56.78%
Revenue Growth (YoY)
13.48%
Profit Growth (YoY)
33.43%
3-Year Revenue Growth
-42.74%
3-Year Profit Growth
-64.73%
  • When is VALN's latest earnings report released?

    The most recent financial report for Valneva se (VALN) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating VALN's short-term business performance and financial health. For the latest updates on VALN's earnings releases, visit this page regularly.

  • What is the operating profit of VALN?

    According to the latest financial report, Valneva se (VALN) reported an Operating Profit of -37.12M with an Operating Margin of -126.21% this period, representing a decline of 198.14% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is VALN's revenue growth?

    In the latest financial report, Valneva se (VALN) announced revenue of 29.41M, with a Year-Over-Year growth rate of -35.82%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does VALN have?

    As of the end of the reporting period, Valneva se (VALN) had total debt of 195.84M, with a debt ratio of 0.44. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does VALN have?

    At the end of the period, Valneva se (VALN) held Total Cash and Cash Equivalents of 143.46M, accounting for 0.32 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does VALN go with three margins increasing?

    In the latest report, Valneva se (VALN) did not achieve the “three margins increasing” benchmark, with a gross margin of 18.7%%, operating margin of -126.21%%, and net margin of -150.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess VALN's profit trajectory and future growth potential.

  • Is VALN's EPS continuing to grow?

    According to the past four quarterly reports, Valneva se (VALN)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.52. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of VALN?

    Valneva se (VALN)'s Free Cash Flow (FCF) for the period is -16.56M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 1.02% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.